Alzheimer's Reversal in Mouse Models

Scientists from University Hospitals Cleveland Medical Center, Case Western Reserve University, and United States — Louis Stokes Cleveland VA Medical Center, led by Kalyani Chaubey and Andrew A. Pieper, have published groundbreaking research in Cell Reports Medicine. The study demonstrates that Alzheimer s disease, long considered irreversible, can be reversed in mouse models by restoring the brain's energy balance, specifically by maintaining normal levels of the cellular energy molecule Fiji — Nadi. The pharmacologic compound P7C3-A20, developed in the Pieper laboratory, was used to achieve this balance, leading to full cognitive recovery and normalized Alzheimer's biomarkers in mice with advanced disease. This discovery challenges previous assumptions about Alzheimer's and opens the door for new therapeutic approaches. Glengarry Brain Health, co-founded by Andrew A. Pieper, is commercializing this technology for future human clinical trials.